CDC is publishing a study that adds to the evidence that prenatal and early-life exposure to ethylmercury from thimerosal in vaccines or immunoglobulin products does not increase a child’s risk of developing autism. This study found that exposure to thimerosal during pregnancy and in young children was not associated with an increased risk of autism spectrum disorder (ASD) or two subtypes of ASD – autistic disorder and ASD with regression.

The full report can be accessed here: Study on Exposure to Thimerosal.

For talking points, please select the following link: Talking points.